Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

11-Oxygenated Androgens in Pcos: Impact of Pcos Phenotypes and First-Line Interventions.

CONTEXT Androgen excess in polycystic ovary syndrome (PCOS)/polyendocrine metabolic ovarian syndrome (PMOS) is classically attributed to ovarian steroids, yet adrenal-derived 11-oxygenated androgens are potent contributors whose regulation and treatment responsiveness in PMOS remains poorly characterized. OBJECTIVE T...

A. Dokras, Allen R. Kunselman, Christina M. Stetter et al. · 0 citations
Review Open access Aug 2026

From Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS): What Obstetricians and Gynecologists Need to Know.

The rationale for the PCOS-to-PMOS rename is discussed, evidence linking PMOS with adverse pregnancy and offspring outcomes is reviewed, and practical implications for obstetric and gynecologic care are outlined.

M. B. Khomami, K. Hoeger, H. Huddleston et al. · 0 citations
Review Open access Sep 2026

Mental Health in Polyendocrine Metabolic Ovarian Syndrome (PMOS): Prevalence, Aetiology and Management Across the Lifespan

Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as polycystic ovary syndrome (PCOS), affects approximately 8%-13% of reproductive-aged women worldwide and is one of the most common endocrine disorders in women. Psychiatric comorbidities represent a substantial but often underrecognised component of this...

A. Dokras · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.